SEP 07, 2016 12:00 PM PDT

Cord Blood Compound To Treat Inflammation

WRITTEN BY: Kara Marker
A compound found in newborns is thought to have the ability to treat excessive inflammation, which could be lifesaving in cases of sepsis. However, the compound disappears from newborn circulation after two weeks of life. 
Infection fighting cells from umbilical cord blood (left) and circulating blood three days after birth (right) from the same prematurely born baby.
First found in umbilical cord blood, the compound works by inhibiting the production of neutrophil extracellular traps (NETs). Thus, the compound is reasonably referred to as neonatal NET inhibitor factor, or nNIF. 

NETs have the ability to damage blood vessels and organs during sepsis, but their intended role is simply to protect the body from pathogens. While a healthy person might have normal-functioning NETs, a person exposed to nicotine from cigarette smoke or someone with sepsis could contain the types of NETs that malfunction, causing excessive inflammatory damage. As for nicotine exposure, the chemical stimulates neutrophils to release NETs and reactive oxygen species. In the present study, researchers think that inhibiting NETs when they “go rogue” might help treat sepsis.

"nNIF is offering insights into how to keep the inflammatory response within prescribed limits,” said lead author Christian Con Yost, MD.

After understanding the ability of nNIFs to inhibit the production NETs, scientists from the University of Utah set out to conduct further tests confirming nNIFs’ ability to control sepsis. Using groups of mice models of sepsis, all from different causes, the researchers used nNIFs to see if they could heal some of the mice. Only 20 mice survived longer than a couple of days without nNIF treatment, but the mice who did receive nNIF were three times as likely to survive.

It makes sense that nNIF remains in the circulation of newborns, because the first weeks after birth a newborn’s immune system is still building up strength and the gut microbiome is only starting to grow. Yost said that the “transient nature” of nNIF in newborn blood is connected to the tight control of inflammation during the first two weeks of a newborn’s life, certainly a vulnerable time.

"The beginning of life is a delicate balance," Yost said. "Our work is showing that it is important to have the right defenses, but they have to be controlled."

The placenta has a similar compound to nNIF, but it’s less potent. 

The current study was recently published in The Journal of Clinical Investigation.
 


Source: University of Utah Health Sciences
Image: Mark Cody/Diana Lim
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 19, 2021
Immunology
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
OCT 19, 2021
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
In patients with hemophilia A—a hereditary disorder where the blood cannot clot properly—their immune system ...
OCT 28, 2021
Immunology
Unlocking a New Target to Treat Gut Inflammation
OCT 28, 2021
Unlocking a New Target to Treat Gut Inflammation
  Immunologists have uncovered a molecular switch in T cells that serves as a prime target for therapeuti ...
NOV 23, 2021
Immunology
Obesity Drives Inflammation, Puts Teeth at Risk
NOV 23, 2021
Obesity Drives Inflammation, Puts Teeth at Risk
Work by University at Buffalo researchers has identified a link between obesity and gum disease. As gum disease escalate ...
DEC 21, 2021
Immunology
Shark Immune Proteins as Pandemic 'Insurance'?
DEC 21, 2021
Shark Immune Proteins as Pandemic 'Insurance'?
Sharks are incredibly hardy creatures—they've survived in marine ecosystems, often unchallenged predators, for ...
JAN 01, 2022
Health & Medicine
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
JAN 01, 2022
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
Novavax, a Maryland-based biotechnology company, gets approval for its more traditional protein-subunit COVID-19 vaccine ...
JAN 13, 2022
Immunology
Gene Unveiled as Missing Link in Antibody Development
JAN 13, 2022
Gene Unveiled as Missing Link in Antibody Development
  Antibodies are a core part of the immune system's pathogen-fighting arsenal, defending the body against bacte ...
Loading Comments...